Title: Managing Menopause: Dealing With The Facts
1Managing Menopause Dealing With The Facts
2Womens Top Health Risks and Causes of Death
- Perception
- Breast Cancer 46
- Other Cancer 16
- Heart Disease 4
- AIDS 4
- Uterine/Ovarian 3
- Reality
- Heart Disease 34
- Other Cancers 12
- Lung Cancer 5
- Stroke 8
- Breast Cancer 4
3Chronic Diseases
- Screening can significantly reduce risk of
cancer/heart disease - The current challenge is dealing with nonfatal,
chronic, age-dependent conditions such as
Alzheimer's, osteoporosis, obesity, and
incontinence - Preventive health care should now be aimed at how
a person can spend their many years as functional
and productive ones
4Menopausal Facts
- The time when the body quits making estrogen
- Average age 51
- Genetically determined
- Other factors involved smoking, underweight,
high altitudes, vegetarian - Not related to race, height, or age of first
menses
5Menopausal Symptoms
- Hot Flashes
- Vaginal dryness
- Sleep disorders
- Mood disturbances
6Hot Flashes
- Most common symptom of menopause
- Affects 68-93 of women
- Symptoms usually last 6 months to 5 years
- Primary reason women seek medical treatment
- 25 remain symptomatic for gt 5 years
7Severity of Reported Hot Flashes
- Severe 51
- Moderate 33
- Mild 16
- Symptoms decrease with time
8Hot Flashes Treatment
- Estrogen clearly the most successful (gt90)
- Decrease night sweats
- Decrease periods of wakefulness
- Increase REM sleep
- Stabilize mood
9Alternative Therapies for Managing Hot Flashes
Phytoestrogens
- Soy protein may decrease hot flashes
- Limited studies, mixed results
- Must be taken as pure soy protein
- No long term studies to show safety
- Dose is 20 grams pure soy protein once or twice
daily
10Alternative Therapies for Managing Hot Flashes
Red Clover
- One study showed 44 reduction
- Dose is 80 mg
- No long term studies
11Alternative Therapies for Managing Hot Flashes
Black Cohosh
- Short term studies show reduction by 70
- Dose is variable
- No study beyond 6 months
12Alternative Therapies for Managing Hot Flashes
SSRIs
- Selective serotonin reuptake inhibitors
- Decrease hot flashes by 50
- Effexor and Paxil the most well studied
- Reasonable option for women with breast cancer
13Alternative Therapies for Managing Hot Flashes
Progesterone
- High dose progesterone reduces hot flashes by 25
85 - High doses associated with weight gain
- Topical progesterone has not been well studied
- Topical absorption is variable
14Alternative Medicine
- 42 of adults in 1998 used some form of
alternative medicine - 60 or 12 million paid cash
- 40 of patients do not inform their doctors
- Not regulated by the FDA
- Ingredients are not tested
- No scientific proof of benefits
15Vaginal Dryness
- A very common complaint
- Generalized daily discomfort
- May result in pain with intercourse
- Primary treatment is oral or vaginal estrogen
- If fearful of systemic estrogen vaginal route
effective with no major side effects - Benefits noted in 2-4 weeks
16Osteoporosis
- 13-18 of Caucasian postmenopausal females have
osteoporosis - 30-50 have osteopenic
- 1998 1.5 million osteoporosis related fractures
- 13 billion dollars in health care services
17Osteoporosis
- Peak bone density is reached at around age 30
- 0.7 decline per year after that
- Potentially 5 per year for spinal bone following
menopause
18Risk Factors for Osteoporosis Nonmodifiable
- Nonmodifiable
- Personal history
- Fracture in a first-degree relative
- Caucasian race
- Advanced age
- Female sex
- Dementia
- Poor health
19Risk Factors for Osteoporosis Modifiable
- Cigarette smoking
- Low body weight
- Estrogen deficiency
- Low calcium intake
- Alcoholism
- Impaired eyesight
- Recurrent falls
- Inadequate physical activity
20Treatment of Osteoporosis with Estrogen
- Decreases fractures by 50 60 in arm and hip
fractures - Decreases up to 80 of vertebral compression
fractures - Requires beginning within 5 years of menopause
- Protective effect lost rapidly after therapy
ended
21Alternative Therapies for the Treatment of
Osteoporosis Bisphosphonates
- Binds to bone to prevent resorption
- Reduces nonvertebral fractures by least 30
- Reduces vertebral fractures by 90
- Can be added to estrogen for combined effects
- Side effects are minimal
- Taken with a full glass of water and remain
upright for 30 minutes without food or beverage - Do not lose effect after discontinued
22Alternatives for Osteoporosis Selective
Estrogen Receptor Modulators (SERMs)
- Synthetic agents
- Beneficial effects on bone and cholesterol while
decreasing the risk of breast cancer and
endometrial cancer - Similar to estrogen in regards to bone
- Full benefits currently under study
- Increase severity of hot flashes
23Colorectal Cancer and Estrogen
- Third most common cancer
- significantly decreases risk with current and
long term use - Most studies show a decrease by 35
- Reason for the benefit is unknown
24Estrogens Benefits and Mental Health
- Sleep disturbances
- Energy
- Cognitive function
- Sexual impairment
- Decreased depression on most depression scores
- Overall increased sense of well-being
25Estrogen and Alzheimer's Disease
- Mixed studies
- Possible decrease in Alzheimer's by 80
- Longer treatment more beneficial
- Estrogen increases cerebral blood flow
- Not helpful once disease is established
26Other Benefits of Estrogen
- Less risk of diabetes
- Decreased body fat
- Decreased arthritis
- Decreased tooth loss by 25
- Decreased vision and hearing loss
27Estrogens Types, Delivery Systems, and Regimens
- There are a variety of estrogens
- Primarily estradiol and estrone
- All estrogens have similar ability
- Impact on bone mineral density
- Hot flashes
28Oral Route Advantages
- Most common
- Must be absorbed through the GI tract
- Increases HDL cholesterol
- Decreases LDL cholesterol
- Decreases some blood clotting factors
- These have been shown to decrease the risk of
cardiovascular disease
29Oral Route Disadvantages
- Increase in triglycerides
- Larger doses required than the patch
- Small risk of GI irritation and nausea
- Increases plasminogen (a blood clotting factor)
30Patch Advantages
- Once or twice per week
- Good choice for those who cannot take pills
- No impact on triglyceride levels
- Equal to oral forms in regards to bone protection
- Potentially safer with a steady state release
31Patch Disadvantages
- Occasional rash from adhesive
- May require progesterone
- Combination estrogen/progesterone patch is larger
than the estrogen patch
32Estrogen Vaginal route
- Easily absorbed for local therapy
- Effective for vaginal dryness and painful
intercourse - Three options for vaginal route exist
- Creams messy, dosing less precise, absorbed
systemically - Tablets twice weekly, minimal absorption
- Vaginal ring 3 month dosing
33Contraindications to Hormone Therapy
- Pregnancy
- Breast cancer
- Estrogen-dependent cancer
- Abnormal genital bleeding
- Blood clots
- Active liver disease
34Estrogen and Blood Clots
- A twofold increase in the risk of blood clots
with hormone therapy - Confined to the first 2 years
- Amounts to an increase of 1.5/10,000 per year
- Risk of death is very low
35The Womens Health Initiative
- Exaggerated in the popular media
- Caused fear and confusion in American women
- No one study has changed the publics opinion in
gynecology
36WHI and Breast Cancer
- Cited an increased of 26
- 8/10,000 cases per year
- Was not statistically significance
- The estrogen only group was not stopped
prematurely because of an increased risk - It takes 10 years for a malignant cell to become
clinically detectable at 1 cm - Increased risk in years 4 and 5 consistent with
hormonal stimulation of preexisting tumors
37Breast cancer
- Over 50 100 studies linking hormone therapy and
breast cancer - Only a few studies shown a small increased risk
- Ever use 1.14
- Current use 1.24
- Past use 1.07
- No study links hormone therapy with a positive
family history
38Mortality from breast cancer when using HRT at
the time of diagnosis
- The majority of studies have shown a decreased
risk of dying from breast cancer when on HRT - Breast cancer in users of HRT appear to be
different compared to nonusers - Smaller tumor size
- More differentiated
- Less spread to lymph nodes
- Less likely to be invasive
39WHI and Cardiovascular Disease
- WHI was labeled as a primary prevention trial
- Debated by average of the participants
- 45 were in their 60s
- 21 in their 70s
- Implies that the majority of patients were
already at risk
40WISDOM
- International British study involving 34,000
women ends this year to evaluate HRT and it
effects on - Fatal and nonfatal ischemic heart disease
- Major osteoporotic fracture
- Breast cancer
- Quality of life
- The study was not stopped prematurely because the
researches felt that the WHI study was not
statistically significant
41Estrogen Risks/Benefits
- Evidence to show a small increased risk of
cardiovascular disease and breast cancer - Evidence to support HRT in decreasing symptoms
such as hot flashes, vaginal dryness, and sleep
problems - Evidence to show HRT decreases osteoporosis and
colorectal cancer - Evidence to support other benefits of HRT
including improved cognition, decreased
Alzheimer's disease, urinary incontinence, and
tooth loss
42Reasonable Alternatives
- Hot flashes herbal regimens may help, SSRIs
have shown significant benefit - Vaginal dryness vaginal rings, creams and
tablets with minimal absorption - Osteoporosis SERMs and Bisphosphonates decrease
bone loss - Cardiovascular disease cholesterol lowering
agents statins decrease the risk of
cardiovascular disease
43Conclusion
- Determine what is important to you
- Evaluating your goals may make more options
available - Focus on the best way to live a healthy and
active life
44Alternatives to osteoporosis SERMs
- Works similar to estrogen in regards to bone loss
- Has been shown to increase bone in spine and
femoral neck - Reduced risk of vertebral fractures by 36
- No decrease in hip or nonvertebral fractures
noticed
45Cognition
- Limited data exists that shows women have better
memory while on estrogen - Estrogen has been shown to promote brain health
by increasing cerebral blood flow - On going trials are being performed that suggest
estrogen long term may decrease Alzheimer's by
50
46Phytoestrogens
- Nonsteroid compounds that bind to the estrogen
receptor - The most common are isoflavones which possess
both estrogenic and antiestrogenic properties - Phytoestrogen rich diet is cited as a factor in
the low incidence of breast cancer and
cardiovascular disease among Asians
47- Phytoestrogens have mixed results in the
literature in regards to alleviating the symptoms
of menopause - There are been equal studies, some showing
benefit while other show no benefit in regards to
hot flashes, libido, vaginal dryness, after 3
months
48- In regards to cardiovascular disease
phytoestrogens have been shown to decrease LDL
cholesterol - This requires the intact soy protein
- Separation of the isoflavone from the protein has
been shown to have no benefit from placebo
49- Small amount of evidence shows that
phytoestrogens may prevent bone loss - This was only vertebral bone
- Hip bone was not affected
- Overall benefit significantly less than estrogen
or SERMs
50Progesterone topical
- Progesterone used twice daily has been shown to
have no effect on bone density, cholesterol - Transdermal progesterone has been shown to have
little systemic absorption and great serum
variability
51- The average age of US women at menopause is 51
years - Most women spend at least one third of their
lifetime in the postmenopause - 1.3 million women reached natural menopause
during 2000 - Induced menopause occurs at a rate of 4,900 women
per day
52- Menstrual irregularities usually begin at age 40
- Only about 10 of women have normal menstrual
cycles from age 40 until menopause - It is not a declining level of estrogen that
causes menstrual cycle irregularities, but
depletion of eggs that the ovary can produce - It has been shown that estrogen levels are higher
just before menopause and some experts theorize
this is to extend the benefits of estrogen before
menopause begins
53- Studies have shown that even if there is an
increased risk of breast cancer the cancer is
localized to the breast and associated with - Earlier detection
- More well-differentiated tumors
- Better survival when compared to nonusers of
hormone therapy - Mortality rates are reduced in users
54- Menopause is not a disease
- Can be looked at as a signal of revival and
renewal for the better - We should consider is a landmark to focus on at
least 30 years of active, healthful living.
55- There are more older people in the United States
than ever before - Year population over 65 of pop
- 1900 3 million 4
- 2000 34 million 12
- 2030 58 million 20
56- Along with this increase is an increase in the
female percentage of the population - Year men women ratio
- 1900 102100
- 2000 23 in the over age 65 age group
- 13 in over 85 age group
- The death rate is higher for men for both medical
and nonmedical reasons including cardiovascular
disease, lung cancer, accidents, suicide,
smoking, alcohol consumption, and higher risk
taking behaviors
57Midlife Assessment Emphasis of prevention
- Beginning in the menopausal years is the ideal
time to focus on preventative care and long term
thinking with three primary goals - Prolong maximal physical, mental, and social well
being - Surveillance for major chronic diseases
- To help smooth the passage from reproductive to
menopausal years
58- Other periodic tests may include
- Fasting glucose
- Thyroid
- Kidney function testing
- Osteoporosis screening
- Immunization status cannot be undervalued for the
elderly and may include - Pneumococcal
- Influenza
- Diphtheria-Tetanus
- Hepatitis
59- Preventative screening may include the following
- Height, weight, and blood pressure
- Annual breast exam
- Annual pap smear screening
- Cholesterol screening every 3 -5 years
- Colorectal screening annually to every 10 years
depending on the screening technique
60- Increasing exercise and muscle mass has also been
shown to improve strength and balance and reduce
falls which may threaten a persons independence
61Basics of Postmenopausal Hormone Therapy
- The first test of hormone therapy to reduce the
effects of aging dates back to 1889 - Estrogen and Progesterone were isolated and
synthesized in the 1930s - Hormone replacement was approved for use in 1942
- 1970 the side effect of endometrial cancer was
identified as a major health concern for those on
estrogen
62- Progestin was added to eliminate the risk of
endometrial cancer and soon it became one of the
most commonly prescribed medications in the US - Now with the recent published report of the Women
Health Initiative hormone replacement again has
been criticized by many
63- The MORE study also evaluated breast cancer risk
on SERMs - Results of study showed a reduced incidence of
newly diagnosed invasive breast cancer by 72 - Estrogen receptor breast cancer was reduced by
84 - Longer term studies are needed to fully evaluate
the overall benefits of SERMs
64Cardiovascular disease
- Major risk factors
- Hypertension
- Smoking
- Diabetes
- obesity
- Men are 3 times more likely to die of heart
disease until women reach menopause - Observational data points to estrogen as the
protective agent
65Estrogen role in cardiovascular disease
- Reduces LDL cholesterol
- Raises HDL cholesterol
- Decreases blood clotting factors
- Together both serve to decrease plaque formation
within the blood vessel wall - While the addition of a progesterone may decrease
the HDL affect there should be no other changes
noticed
66- Although there appears to be a role for primary
prevention this is not true for secondary
prevention - two large studies suggest that women taking
hormone therapy with known heart disease may have
increased risk of heart attack in the first two
years
67- Endometrial cancer
- It is well known that estrogen without
progesterone is associated with endometrial
cancer - Addition of progesterone negates the risk
68- Endometrial cancer
- It is well known that estrogen without
progesterone is associated with endometrial
cancer - Addition of progesterone negates the risk
69- Follow up was not long enough to provide outcomes
of the breast cancer in the participants
Oral Route Advantages
70- Creams
- Dosing less precise
- Messy
- Can be absorbed systemically so progesterone is
required for an intact uterus - Ring left in place for 3 months, systemic
absorption not significant - Tablets twice a week maintenance dosing, little
systemic absorption - All can be used with patients who have liver
disease, inability to tolerate side effects of
systemic hormone, and do not adversely affect
cholesterol
71- Creams
- Dosing less precise
- Messy
- Can be absorbed systemically so progesterone is
required for an intact uterus - Ring left in place for 3 months, systemic
absorption not significant - Tablets twice a week maintenance dosing, little
systemic absorption - All can be used with patients who have liver
disease, inability to tolerate side effects of
systemic hormone, and do not adversely affect
cholesterol
72Prevention and Treatment with Estrogen
- Inhibits bone resorption
- Promotes absorption of calcium
- Increased vitamin D
- Conserves calcium lost from the kidneys
- Increases the survival of the cells that form new
bone - Estrogen is primary prevention for osteoporosis
73- Bisphosphonates are only indicated for bone loss
and has no other benefits - Unlike estrogen, they do not lose effect after
discontinuation
74Alternatives to osteoporosis
- SERMs
- Multiple outcomes of Raloxifene Evaluation (MORE)
trial was performed to evaluate Raloxifene on
osteoporosis fractures - At 3 years vertebral fractures was significantly
reduced - Did not show protective benefit of hip fractures
when compared to placebo - Did increase femoral neck bone mineral density
by over 2 over the 3 year trial
75- SERMs unfortunately have been shown to increase
the frequency and severity of hot flashes
76WHI and Breast Cancer Continued
- WHI study results on breast cancer did not
actually reach statistical significance - A analysis of 51 studies from the world
literature found a 14 increased risk in
ever-users, but no increased risk associated with
past use or family history - This disease was localized to the breast
77Lifestyle adjustments
- Cigarette smoking the single most preventable
cause of illness and death in the US since 1970 - Possibly worse for women than men
- 1-4 cigarettes per day increases risk of death
from heart disease by 2.5X - Increases other chronic diseases such as
- stroke
- osteoporosis
- pulmonary disease
- cervical and bladder cancer
- Alzheimer's
- worsens cholesterol
- urinary incontinence
- tooth loss
78- Alcohol use in moderation (1-2 drinks/day) has
been shown to decrease heart disease by raising
HDL cholesterol - Greater than 2 drinks/day has been shown to
- damage heart muscle
- alter heart rhythm
- constrict blood vessels
- raise blood pressure
- increase risk of stroke and liver disease
- increase the risk of osteoporosis
- Minor effects also include worsening of hot
flashes, interfere with sleep patterns, and
exaggerate emotional stress
79- Physical activity the magic cure has clearly
been shown to - lower blood pressure
- reduce weight
- slow bone loss
- build muscle mass
- overcome insomnia
- relieve stress
- lower risk of heart disease
- Stroke
- Diabetes
- high cholesterol
- Ulcers
- pulmonary disease
- breast and reproductive cancers
80- Minimal cardiac fitness is 30 minutes 3 days/week
- New information shows that optimal fitness is
obtained with 1 hour 5-7 days/week - Nurses health study showed that brisk walking for
3 or more hours a week decreased the risk of
heart attacks by 30-40 - Only weight bearing exercises can increase bone
density
81Nutrition
- 20-30 of women beyond age 30 are more than 20
overweight - Women have more problems with weight loss because
of a decreasing metabolic rate with age - Recommended calcium intake is
- 1000mg for premenopausal/women taking estrogen
1500 mg for women over 65 not on estrogen - Vitamin D 400IU is also required for optimal
absorption of calcium